EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Guodong Liu, Lan Kong, Ping Du

Papillomavirus Research · 2016-12 · 2 · 1-8

DOI: 10.1016/j.pvr.2015.10.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Papillomavirus Research, 2016-12. Verfasst von Guodong Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania. Hauptthemen laut MEDLINE: Immunization Programs. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US. METHODS: We conducted a retrospective cohort study using the 2008-2011 MarketScan data to examine HPV vaccine completion and dose adherence among commercially insured females aged 9-26 years. We performed multivariable logistic regression models to examine factors related to HPV vaccine completion and HPV vaccine dose adherence. RESULTS: Among 378,484 females aged 9-26 years who initiated HPV vaccination, only 29.4% completed HPV vaccination. Compared with females receiving vaccines from primary care providers, those receiving vaccines from OB/GYN providers were more likely to complete the vaccine series. Age at HPV vaccine initiation, health insurance plan, seasonal pattern, and flu vaccination were also significantly associated with vaccine completion. Among 111,286 females who completed HPV vaccination, 62.4% received all doses within 30 days of the recommended schedules. Similar factors relating to HPV vaccine completion were consistently associated with HPV vaccine dose adherence. However, younger age (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunization ProgramsAdolescentAdultChildCohort StudiesFemaleHumansImmunization ScheduleInsurance CoverageMalePapillomavirus InfectionsPapillomavirus VaccinesRegression AnalysisRetrospective StudiesVaccinationYoung Adult

Stichwörter der Autor:innen

Commercially insured femalesHPV vaccine completionHPV vaccine dose adherence

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
  • Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania ; Department of Medicine, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Liu, G., Kong, L., & Du, P. (2016). HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US. Papillomavirus Research, 2, 1-8. https://doi.org/10.1016/j.pvr.2015.10.001

Vancouver

Liu G, Kong L, Du P. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US. Papillomavirus Research. 2016;2:1-8. doi:10.1016/j.pvr.2015.10.001

BibTeX
@article{Liu2016,
  author = {Liu, Guodong and Kong, Lan and Du, Ping},
  title = {HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US},
  journal = {Papillomavirus Research},
  year = {2016},
  volume = {2},
  pages = {1--8},
  doi = {10.1016/j.pvr.2015.10.001}
}
Kostenlos starten →